Statistics from Altmetric.com
Ibuprofen is used in neonates to treat patent ductus arteriosus (PDA). Several randomised controlled trials have compared oral ibuprofen to intravenous for closing of PDA. Surprisingly, oral administration seems more effective than same dose intravenously. This is unusual from a pharmacological perspective. In general, it is unlikely that the systemic effect of a drug will be better from oral administration than the same dose administered intravenously.
A Cochrane meta-analysis including five studies in the comparison of oral versus intravenous ibuprofen found that oral administration of ibuprofen was more effective in PDA closure (risk ratio favouring oral ibuprofen 0.38 (95% CI 0.26 to 0.56)). Need for surgical closure of the ductus had similar effect size but was insignificant (risk ratio 0.41, 95% CI 0.14 to 1.21), …
Contributors TBJ, JPK and JTA contributed to all steps in the making of this letter.
Funding This study was funded by an unrestricted grant from P. Carl Petersens Fond (foundation) and grant no: 18071.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.